Literature DB >> 12837103

An oxazaphospholidine approach for the stereocontrolled synthesis of oligonucleoside phosphorothioates.

Natsuhisa Oka1, Takeshi Wada, Kazuhiko Saigo.   

Abstract

The stereocontrolled synthesis of oligodeoxyribonucleoside phosphorothioates (PS-ODNs) using nucleoside 3'-O-oxazaphospholidine derivatives as monomer units is described. 2-Chloro-1,3,2-oxazaphospholidine derivatives were prepared from six kinds of enantiopure 1,2-amino alcohols and used for the phosphitylation reactions of 5'-O-protected nucleosides. A detailed study of these reactions revealed that the diastereoselectivity of the reaction depended on the structure of the enantiopure 1,2-amino alcohol, the reaction temperature, and the amine used as a scavenger of HCl. In addition, ab initio molecular orbital calculations for the 2-chlorooxazaphospholidine derivatives were carried out to elucidate the mechanism of these diastereoselective phosphitylation reactions. The LUMO of the 2-chloro-5-phenyloxazaphospholidine derivatives on the phosphorus atom was found to be almost orthogonal to the P-Cl bond. This LUMO may be involved in the phosphitylation reactions with predominant retention of the P-configuration. A series of dialkyl(cyanomethyl)ammonium salts were developed and used as activators for the condensation reactions of the diastereopure nucleoside 3'-O-oxazaphospholidines with 3'-O-protected nucleosides. In the presence of the new activators, the reactions proceeded rapidly to give the corresponding dinucleoside phosphite triesters. The diastereoselectivity of the condensation reaction did not depend on the counteranion but on the structure of the dialkyl(cyanomethyl)amine. In the presence of the activator, which consists of a relatively small dialkyl(cyanomethyl)amine, the condensation proceeded with excellent diastereoselectivity. After sulfurization and deprotection, diastereopure (R(p))- and (S(p))-dinucleoside phosphorothioates were obtained in excellent yields. The present methodology was also applied to the solid-phase synthesis of stereoregulated PS-ODNs. all-(R(p))-[T(PS)](3)T, all-(S(p))-[T(PS)](3)T, all-(R(p))-d[G(PS)A(PS)C(PS)]T, and all-(R(p))-[T(PS)](9)T were synthesized on a highly cross-linked polystyrene resin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837103     DOI: 10.1021/ja034502z

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  8 in total

Review 1.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

Review 2.  Antisense technology: A review.

Authors:  Stanley T Crooke; Xue-Hai Liang; Brenda F Baker; Rosanne M Crooke
Journal:  J Biol Chem       Date:  2021-02-16       Impact factor: 5.157

3.  A P(V) platform for oligonucleotide synthesis.

Authors:  Yazhong Huang; Kyle W Knouse; Shenjie Qiu; Wei Hao; Natalia M Padial; Julien C Vantourout; Bin Zheng; Stephen E Mercer; Javier Lopez-Ogalla; Rohan Narayan; Richard E Olson; Donna G Blackmond; Martin D Eastgate; Michael A Schmidt; Ivar M McDonald; Phil S Baran
Journal:  Science       Date:  2021-09-09       Impact factor: 63.714

4.  Catalytic asymmetric and stereodivergent oligonucleotide synthesis.

Authors:  Aaron L Featherston; Yongseok Kwon; Matthew M Pompeo; Oliver D Engl; David K Leahy; Scott J Miller
Journal:  Science       Date:  2021-02-12       Impact factor: 47.728

5.  Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides.

Authors:  Michael E Østergaard; Cheryl L De Hoyos; W Brad Wan; Wen Shen; Audrey Low; Andres Berdeja; Guillermo Vasquez; Susan Murray; Michael T Migawa; Xue-Hai Liang; Eric E Swayze; Stanley T Crooke; Punit P Seth
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

6.  Synthesis and properties of DNA oligomers containing stereopure phosphorothioate linkages and C-5 modified deoxyuridine derivatives.

Authors:  Rintaro Iwata Hara; Reijiro Yoshino; Yohei Nukaga; Yusuke Maeda; Kazuki Sato; Takeshi Wada
Journal:  RSC Adv       Date:  2020-09-15       Impact factor: 4.036

7.  Refining LNA safety profile by controlling phosphorothioate stereochemistry.

Authors:  Erik Daa Funder; Nanna Albæk; Annie Moisan; Sabine Sewing; Troels Koch
Journal:  PLoS One       Date:  2020-06-12       Impact factor: 3.240

8.  Enhanced affinity of racemic phosphorothioate DNA with transcription factor SATB1 arising from diastereomer-specific hydrogen bonds and hydrophobic contacts.

Authors:  Kazuhiko Yamasaki; Yukie Akutsu; Tomoko Yamasaki; Makoto Miyagishi; Tomomi Kubota
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.